Veracyte
VCYT
64 hedge funds and large institutions have $110M invested in Veracyte in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
63% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 16
49% more capital invested
Capital invested by funds: $73.5M → $110M (+$36.2M)
5% more funds holding
Funds holding: 61 → 64 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $170K
Top Buyers
Top Sellers
VCYT Hedge Fund Activity: Q4 2015 in Review
64 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2015, worth a combined $110M — up 49% from $73.5M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VCYT positions and 4 closed out — a net gain of 3 holders — while 26 added to existing stakes and 16 trimmed.
The largest buyer was Acuta Capital Partners, adding an estimated $5.46M. The largest seller was Camber Capital Management, exiting entirely with an estimated $4.27M sold.
- 64 institutional investors held Veracyte (VCYT) as of Q4 2015, up from 61 in Q3 2015.
- Funds reported $110M of Veracyte stock for Q4 2015, up 49% quarter-over-quarter.
- 7 funds opened new Veracyte positions in Q4 2015 and 4 closed out, a net change of +3 holders.
- The largest Veracyte buyer in Q4 2015 was Acuta Capital Partners, an estimated $5.46M added.
- The largest Veracyte seller in Q4 2015 was Camber Capital Management, an estimated $4.27M sold.
Based on aggregated 13F filings for Q4 2015.